Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Low Grade Serous Ovarian Cancer × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 57 Neoplasms 7 Neoplasm Metastasis 5 Advanced Breast Cancer 4 Neoplasms by Site 2 Breast Diseases 2 Skin Diseases 1 Recurrence 1 Quality of Life 1 Low Grade Serous Ovarian Cancer 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Camurati-Engelmann Syndrome 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Bone Density 1 Advanced Metastatic Breast Cancer 1

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡